Barclays PLC Vaxxinity, Inc. Transaction History
Barclays PLC
- $327 Billion
- Q2 2024
A detailed history of Barclays PLC transactions in Vaxxinity, Inc. stock. As of the latest transaction made, Barclays PLC holds 2 shares of VAXX stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2
Previous 29,835
99.99%
Holding current value
$0
Previous $21,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding VAXX
# of Institutions
7Shares Held
287KCall Options Held
0Put Options Held
0-
Pathstone Family Office, LLC Englewood, NJ154KShares$1,5380.0% of portfolio
-
Xtx Topco LTD London, X067.1KShares$6710.0% of portfolio
-
ETF Managers Group, LLC Summit, NJ43.8KShares$4380.0% of portfolio
-
Glenmede Trust CO Na Philadelphia, PA19.2KShares$1910.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ2.39KShares$230.0% of portfolio
About Vaxxinity, Inc.
- Ticker VAXX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 112,150,000
- Market Cap $1.12M
- Description
- Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States. The company engages in developing UB-311 that targets toxic forms of aggregated amyloid-b in the brain to fight Alzheimer's disease (AD) that is in phase 2 clinical trial; UB-312 that...